Clinical Trials
23 trialsNCT01150045 2026-05-19
Oxaliplatin, Leucovorin Calcium, and Fluorouracil With or Without Celecoxib in Treating Patients With Stage III Colon Cancer Previously Treated With Surgery
Alliance for Clinical Trials in Oncology
Phase 3 Completed
NCT04176419 2024-11-12
Perioperative Analgesia on Postoperative Opioid Usage and Pain Control in H&N Cancer Surgery
Case Comprehensive Cancer Center
Phase 3 Terminated
NCT06545526 2024-08-09
Chemopreventive Effect of Combination of Celecoxib and Metformin in Patients With Familial Adenomatous Polyposis
Yonsei University
Phase 3 Recruiting
NCT05327751 2022-04-14
HFS
Tanta University
Phase 3 Unknown
NCT00585312 2021-02-21
CHIP
Pfizer
Phase 3 Terminated
NCT02429427 2020-06-23
REACT
Imperial College London
Phase 3 Completed
NCT02108366 2019-10-21
Treatment of Severe Influenza A Infection
The University of Hong Kong
Phase 3 Completed
NCT03059238 2019-08-13
Parecoxib Versus Celecoxib Versus Oxycodone in Pain Control for Transcatheter Chemoembolization Procedure
Sun Yat-sen University
Phase 3 Completed
NCT03184493 2019-05-31
XBD
Guangxi Medical University
Phase 3 Unknown
NCT01041781 2018-07-23
Gemcitabine Hydrochloride or Pemetrexed Disodium and Carboplatin With or Without Celecoxib in Treating Patients With Advanced Non-Small Cell Lung Cancer
Alliance for Clinical Trials in Oncology
Phase 3 Terminated
NCT00305643 2015-12-24
Celecoxib in Preventing Hand/Foot Syndrome Caused By Capecitabine With Metastatic Breast or Colorectal Cancer
M.D. Anderson Cancer Center
Phase 3 Terminated
NCT00085163 2015-10-20
Celecoxib Combined With Fluorouracil and Leucovorin in Treating Patients With Resected Stage III Adenocarcinoma (Cancer) of the Colon
European Organisation for Research and Treatment of Cancer - EORTC
Phase 3 Completed
NCT02537925 2015-09-02
The Effect of COX-2 Inhibitor on Radiosensitivity in Nasopharyngeal Carcinoma
Nanning Second People's Hospital
Phase 3 Unknown
NCT00005094 2013-04-12
Celecoxib to Prevent Colorectal Cancer in Patients Who Have Undergone Surgery to Remove Polyps
National Cancer Institute (NCI)
Phase 3 Completed
NCT00087256 2013-01-07
Celecoxib in Preventing Polyps in Patients Who Have Undergone Surgery for Stage I Colon Cancer
NSABP Foundation Inc
Phase 3 Terminated
NCT00064181 2012-09-24
Combination Chemotherapy With or Without Celecoxib in Treating Patients With Metastatic Colorectal Cancer
European Organisation for Research and Treatment of Cancer - EORTC
Phase 3 Completed
NCT00981201 2012-08-01
Celecoxib as a Chemopreventive Agent in Current and Former Smokers
M.D. Anderson Cancer Center
Phase 3 Completed
NCT00525096 2011-06-30
Exemestane + Celecoxib vs Exemestane + Placebo in Metastatic Breast Cancer
ARCAGY/ GINECO GROUP
Phase 3 Completed
NCT00300729 2009-06-30
CYCLUS
University Hospital, Linkoeping
Phase 3 Unknown
NCT00603759 2008-01-29
COX-2 Inhibitor With Concurrent Chemoradiation in Locally Advanced Head & Neck Carcinoma
Tehran University of Medical Sciences
Phase 3 Unknown
NCT00486460 2007-06-14
Phase III Trial of Gemcitabine, Curcumin and Celebrex in Patients With Advance or Inoperable Pancreatic Cancer
Tel-Aviv Sourasky Medical Center
Phase 3 Unknown
NCT00295035 2006-02-22
Phase III Trial of Gemcitabine, Curcumin and Celebrex in Patients With Metastatic Colon Cancer
Tel-Aviv Sourasky Medical Center
Phase 3 Unknown
NCT00211952 2005-09-21
Adjuvant Celecoxib in Completely Resected pN1-2 NSCLC Patients
Medical University of Gdansk
Phase 3 Suspended